Considering that the blood cholesterol levels were much lower than those in high-cholesterol diet-fed apoE-deficient mice and wild-type mice carrying gain-of-function mutations of PCSK9 [31], hypercholesterolemia is not likely to contribute to the augmented AAA development in O-HFD. The gene discussed is PCSK9; the disease is triple-A syndrome.